190 related articles for article (PubMed ID: 16183028)
1. Vancomycin covalently bonded to titanium beads kills Staphylococcus aureus.
Jose B; Antoci V; Zeiger AR; Wickstrom E; Hickok NJ
Chem Biol; 2005 Sep; 12(9):1041-8. PubMed ID: 16183028
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin covalently bonded to titanium alloy prevents bacterial colonization.
Antoci V; King SB; Jose B; Parvizi J; Zeiger AR; Wickstrom E; Freeman TA; Composto RJ; Ducheyne P; Shapiro IM; Hickok NJ; Adams CS
J Orthop Res; 2007 Jul; 25(7):858-66. PubMed ID: 17415753
[TBL] [Abstract][Full Text] [Related]
3. Covalently attached vancomycin provides a nanoscale antibacterial surface.
Antoci V; Adams CS; Parvizi J; Ducheyne P; Shapiro IM; Hickok NJ
Clin Orthop Relat Res; 2007 Aug; 461():81-7. PubMed ID: 17549031
[TBL] [Abstract][Full Text] [Related]
4. Local protection for surgical implants.
Lucke M
Chem Biol; 2005 Sep; 12(9):958-9; discussion 1041-8. PubMed ID: 16183019
[TBL] [Abstract][Full Text] [Related]
5. Covalent bonding of vancomycin to Ti6Al4V alloy pins provides long-term inhibition of Staphylococcus aureus colonization.
Edupuganti OP; Antoci V; King SB; Jose B; Adams CS; Parvizi J; Shapiro IM; Zeiger AR; Hickok NJ; Wickstrom E
Bioorg Med Chem Lett; 2007 May; 17(10):2692-6. PubMed ID: 17369042
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin derivative photopolymerized to titanium kills S. epidermidis.
Lawson MC; Bowman CN; Anseth KS
Clin Orthop Relat Res; 2007 Aug; 461():96-105. PubMed ID: 17549033
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin bound to Ti rods reduces periprosthetic infection: preliminary study.
Antoci V; Adams CS; Hickok NJ; Shapiro IM; Parvizi J
Clin Orthop Relat Res; 2007 Aug; 461():88-95. PubMed ID: 17549034
[TBL] [Abstract][Full Text] [Related]
8. Combined efficacy of clarithromycin plus cefazolin or vancomycin against Staphylococcus aureus biofilms formed on titanium medical devices.
Fujimura S; Sato T; Mikami T; Kikuchi T; Gomi K; Watanabe A
Int J Antimicrob Agents; 2008 Dec; 32(6):481-4. PubMed ID: 18790609
[TBL] [Abstract][Full Text] [Related]
9. Characterization and antibacterial performance of electrodeposited chitosan-vancomycin composite coatings for prevention of implant-associated infections.
Ordikhani F; Tamjid E; Simchi A
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():240-8. PubMed ID: 24907757
[TBL] [Abstract][Full Text] [Related]
10. An unexpected amide bond cleavage: poly (ethylene glycol) transport forms of vancomycin. 2.
Greenwald RB; Zhao H; Peng P; Longley CB; Dai QH; Xia J; Martinez A
Eur J Med Chem; 2005 Aug; 40(8):798-804. PubMed ID: 16122582
[TBL] [Abstract][Full Text] [Related]
11. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
Pillai SK; Wennersten C; Venkataraman L; Eliopoulos GM; Moellering RC; Karchmer AW
Clin Infect Dis; 2009 Oct; 49(8):1169-74. PubMed ID: 19769538
[TBL] [Abstract][Full Text] [Related]
12. Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus.
Karampatakis V; Papanikolaou T; Giannousis M; Goulas A; Mandraveli K; Kilmpasani M; Alexiou-Daniel S; Mirtsou-Fidani V
Acta Ophthalmol; 2009 Aug; 87(5):555-8. PubMed ID: 18700884
[TBL] [Abstract][Full Text] [Related]
13. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
Appelbaum PC
Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():16-23. PubMed ID: 16445720
[TBL] [Abstract][Full Text] [Related]
14. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
Sakoulas G; Moellering RC
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
[TBL] [Abstract][Full Text] [Related]
15. Nosocomial methicillin--resistant Staphylococcus aureus with reduced susceptibility to vancomycin.
Bhat G; Kamath S; Hussain A
Indian J Pathol Microbiol; 2006 Apr; 49(2):311-2. PubMed ID: 16933753
[No Abstract] [Full Text] [Related]
16. In vitro time-kill activities of rifalazil, alone and in combination with vancomycin, against logarithmic and stationary cultures of Staphylococcus aureus.
Osburne MS; Rothstein DM; Farquhar R; Murphy CK
J Antibiot (Tokyo); 2006 Feb; 59(2):80-5. PubMed ID: 16629407
[TBL] [Abstract][Full Text] [Related]
17. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
[TBL] [Abstract][Full Text] [Related]
18. Reduction of postoperative spinal implant infection using gentamicin microspheres.
Stall AC; Becker E; Ludwig SC; Gelb D; Poelstra KA
Spine (Phila Pa 1976); 2009 Mar; 34(5):479-83. PubMed ID: 19247168
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin Functionalized Nanoparticles for Bactericidal Biomaterial Surfaces.
Pichavant L; Carrié H; Nguyen MN; Plawinski L; Durrieu MC; Héroguez V
Biomacromolecules; 2016 Apr; 17(4):1339-46. PubMed ID: 26938371
[TBL] [Abstract][Full Text] [Related]
20. Delivery of antibiotics from cementless titanium-alloy cubes may be a novel way to control postoperative infections.
Bezuidenhout MB; van Staden AD; Oosthuizen GA; Dimitrov DM; Dicks LM
Biomed Res Int; 2015; 2015():856859. PubMed ID: 25861649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
